Herborium Group, Inc.
HBRM · OTC
2/28/2025 | 11/30/2024 | 8/31/2024 | 5/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 0.00% | 0.00% | 0.00% | -0.51% |
| EV / EBITDA | 164.06 | -6.65 | 94.35 | 1,171.95 |
| Quality | ||||
| ROIC | -0.57% | 11.20% | -0.53% | -0.06% |
| Gross Margin | 56.94% | 98.62% | 52.20% | 52.00% |
| Cash Conversion Ratio | -3.04 | 3.44 | -1.87 | -1.40 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.84% | -2.48% | -0.78% | -0.28% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 80.77 | -3.27 | 62.25 | 578.50 |
| Interest Coverage | 0.00 | -7.84 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 8.25 | 0.28 | 10.75 | 6.44 |
| Cash Conversion Cycle | -39.36 | -3,897.62 | -29.99 | -8.18 |